Core Laboratories (NYSE: CLB) reported Q4 EPS of $0.21, $0.16 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $138.26 million versus the consensus estimate of $160.5 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.